47 related articles for article (PubMed ID: 36422798)
1. Induction of ferroptosis and apoptosis in endometrial cancer cells by dihydroisotanshinone I.
Wu CY; Yang YH; Lin YS; Shu LH; Liu HT; Wu YH; Wu YH
Heliyon; 2023 Nov; 9(11):e21652. PubMed ID: 38027826
[TBL] [Abstract][Full Text] [Related]
2. An Isoxazoloquinone Derivative Inhibits Tumor Growth by Targeting STAT3 and Triggering Its Ubiquitin-Dependent Degradation.
Xie Y; Zhu S; Chen L; Liu H; Peng T; Ming Z; Zou Z; Hu X; Luo W; Peng K; Nie Y; Luo T; Ma D; Liu S; Luo Z
Cancers (Basel); 2023 Apr; 15(9):. PubMed ID: 37173892
[TBL] [Abstract][Full Text] [Related]
3. The Anticancer Effect of Napabucasin (BBI608), a Natural Naphthoquinone.
Shao Z; Wang H; Ren H; Sun Y; Chen X
Molecules; 2023 Jul; 28(15):. PubMed ID: 37570646
[TBL] [Abstract][Full Text] [Related]
4. STAT3 inhibitor BBI608 reduces patient-specific primary cell viability of cervical and endometrial cancer at a clinical-relevant concentration.
Chen J; Huang S; Li H; Li Y; Zeng H; Hu J; Lin Y; Cai H; Deng P; Song T; Guan T; Zeng H; Liu M
Clin Transl Oncol; 2023 Mar; 25(3):662-672. PubMed ID: 36422798
[TBL] [Abstract][Full Text] [Related]
5. Targeted activation of Stat3 in combination with paclitaxel results in increased apoptosis in epithelial ovarian cancer cells and a reduced tumour burden.
Li H; Qian Y; Wang X; Pi R; Zhao X; Wei X
Cell Prolif; 2020 Jan; 53(1):e12719. PubMed ID: 31778258
[TBL] [Abstract][Full Text] [Related]
6. A redox-responsive nanosystem to suppress chemoresistant lung cancer through targeting STAT3.
Feng Q; Chen J; Huang J; Li X; Liu X; Xiao C; Zheng X; Chen X; Li J; Gu Z; Luo K; Xiao K; Li W
J Control Release; 2023 Nov; 363():349-360. PubMed ID: 37748583
[TBL] [Abstract][Full Text] [Related]
7. STAT3 inhibitor BBI608 enhances the antitumor effect of gefitinib on EGFR-mutated non-small cell lung cancer cells.
Wang Q; Lu B; Zhang Y; Yu J; Guo J; Zhou Q; Lv H; Sun Y
Hum Cell; 2021 Nov; 34(6):1855-1865. PubMed ID: 34370268
[TBL] [Abstract][Full Text] [Related]
8. Napabucasin (BBI608) eliminate AML cells in vitro and in vivo via inhibition of Stat3 pathway and induction of DNA damage.
Bi S; Chen K; Feng L; Fu G; Yang Q; Deng M; Zhao H; Li Z; Yu L; Fang Z; Xu B
Eur J Pharmacol; 2019 Jul; 855():252-261. PubMed ID: 31085238
[TBL] [Abstract][Full Text] [Related]
9. Stat3 activation in human endometrial and cervical cancers.
Chen CL; Hsieh FC; Lieblein JC; Brown J; Chan C; Wallace JA; Cheng G; Hall BM; Lin J
Br J Cancer; 2007 Feb; 96(4):591-9. PubMed ID: 17311011
[TBL] [Abstract][Full Text] [Related]
10. Role of the JAK/STAT Pathway in Cervical Cancer: Its Relationship with HPV E6/E7 Oncoproteins.
Gutiérrez-Hoya A; Soto-Cruz I
Cells; 2020 Oct; 9(10):. PubMed ID: 33076315
[TBL] [Abstract][Full Text] [Related]
11. Napabucasin overcomes cisplatin resistance in ovarian germ cell tumor-derived cell line by inhibiting cancer stemness.
Schmidtova S; Dorssers LCJ; Kalavska K; Gillis AJM; Oosterhuis JW; Stoop H; Miklikova S; Kozovska Z; Burikova M; Gercakova K; Durinikova E; Chovanec M; Mego M; Kucerova L; Looijenga LHJ
Cancer Cell Int; 2020; 20():364. PubMed ID: 32774158
[TBL] [Abstract][Full Text] [Related]
12. Design, synthesis and biological evaluation of novel potent STAT3 inhibitors based on BBI608 for cancer therapy.
Feng KR; Wang F; Shi XW; Tan YX; Zhao JY; Zhang JW; Li QH; Lin GQ; Gao D; Tian P
Eur J Med Chem; 2020 Sep; 201():112428. PubMed ID: 32603980
[TBL] [Abstract][Full Text] [Related]
13. Tocilizumab potentiates cisplatin cytotoxicity and targets cancer stem cells in triple-negative breast cancer.
Alraouji NN; Al-Mohanna FH; Ghebeh H; Arafah M; Almeer R; Al-Tweigeri T; Aboussekhra A
Mol Carcinog; 2020 Sep; 59(9):1041-1051. PubMed ID: 32537818
[TBL] [Abstract][Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
